Managing bolus insulin dosing can be a significant burden for people with diabetes on basal-bolus insulin therapy, who must diligently self-manage food, activity, stress, sleep, and insulin dose calculations several times daily.
Chronic kidney disease (CKD) affects one-quarter to one-third of adults with diabetes in the USA.1 2 Patients with CKD and type 2 diabetes have an elevated risk of cardiovascular (CV) disease and can eventually progress to end-stage kidney disease (ESKD).3–5